BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24796111)

  • 1. [Recent progress and prospects for research on urate efflux transporter ABCG2].
    Ichida K
    Nihon Rinsho; 2014 Apr; 72(4):757-65. PubMed ID: 24796111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABCG2 dysfunction increases the risk of renal overload hyperuricemia.
    Matsuo H; Takada T; Nakayama A; Shimizu T; Sakiyama M; Shimizu S; Chiba T; Nakashima H; Nakamura T; Takada Y; Sakurai Y; Hosoya T; Shinomiya N; Ichida K
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):266-74. PubMed ID: 24940678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased extra-renal urate excretion is a common cause of hyperuricemia.
    Ichida K; Matsuo H; Takada T; Nakayama A; Murakami K; Shimizu T; Yamanashi Y; Kasuga H; Nakashima H; Nakamura T; Takada Y; Kawamura Y; Inoue H; Okada C; Utsumi Y; Ikebuchi Y; Ito K; Nakamura M; Shinohara Y; Hosoyamada M; Sakurai Y; Shinomiya N; Hosoya T; Suzuki H
    Nat Commun; 2012 Apr; 3():764. PubMed ID: 22473008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABCG2/BCRP dysfunction as a major cause of gout.
    Matsuo H; Takada T; Ichida K; Nakamura T; Nakayama A; Suzuki H; Hosoya T; Shinomiya N
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1117-28. PubMed ID: 22132966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of ABCG2 dysfunction as a major factor contributing to gout.
    Matsuo H; Takada T; Ichida K; Nakamura T; Nakayama A; Takada Y; Okada C; Sakurai Y; Hosoya T; Kanai Y; Suzuki H; Shinomiya N
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1098-104. PubMed ID: 22132963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population.
    Matsuo H; Takada T; Ichida K; Nakamura T; Nakayama A; Ikebuchi Y; Ito K; Kusanagi Y; Chiba T; Tadokoro S; Takada Y; Oikawa Y; Inoue H; Suzuki K; Okada R; Nishiyama J; Domoto H; Watanabe S; Fujita M; Morimoto Y; Naito M; Nishio K; Hishida A; Wakai K; Asai Y; Niwa K; Kamakura K; Nonoyama S; Sakurai Y; Hosoya T; Kanai Y; Suzuki H; Hamajima N; Shinomiya N
    Sci Transl Med; 2009 Nov; 1(5):5ra11. PubMed ID: 20368174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABCG2 dysfunction causes hyperuricemia due to both renal urate underexcretion and renal urate overload.
    Matsuo H; Nakayama A; Sakiyama M; Chiba T; Shimizu S; Kawamura Y; Nakashima H; Nakamura T; Takada Y; Oikawa Y; Takada T; Nakaoka H; Abe J; Inoue H; Wakai K; Kawai S; Guang Y; Nakagawa H; Ito T; Niwa K; Yamamoto K; Sakurai Y; Suzuki H; Hosoya T; Ichida K; Shimizu T; Shinomiya N
    Sci Rep; 2014 Jan; 4():3755. PubMed ID: 24441388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion.
    Hoque KM; Dixon EE; Lewis RM; Allan J; Gamble GD; Phipps-Green AJ; Halperin Kuhns VL; Horne AM; Stamp LK; Merriman TR; Dalbeth N; Woodward OM
    Nat Commun; 2020 Jun; 11(1):2767. PubMed ID: 32488095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Two Dysfunctional Variants in the ABCG2 Urate Transporter Associated with Pediatric-Onset of Familial Hyperuricemia and Early-Onset Gout.
    Toyoda Y; Pavelcová K; Bohatá J; Ješina P; Kubota Y; Suzuki H; Takada T; Stiburkova B
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout.
    Woodward OM; Köttgen A; Coresh J; Boerwinkle E; Guggino WB; Köttgen M
    Proc Natl Acad Sci U S A; 2009 Jun; 106(25):10338-42. PubMed ID: 19506252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout-An Update.
    Eckenstaler R; Benndorf RA
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABCG2 as a therapeutic target candidate for gout.
    Fujita K; Ichida K
    Expert Opin Ther Targets; 2018 Feb; 22(2):123-129. PubMed ID: 29264928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABCG2 is a high-capacity urate transporter and its genetic impairment increases serum uric acid levels in humans.
    Nakayama A; Matsuo H; Takada T; Ichida K; Nakamura T; Ikebuchi Y; Ito K; Hosoya T; Kanai Y; Suzuki H; Shinomiya N
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1091-7. PubMed ID: 22132962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms and decreased protein expression of ABCG2 urate transporters are associated with susceptibility to gout, disease severity and renal-overload hyperuricemia.
    Pálinkás M; Szabó E; Kulin A; Mózner O; Rásonyi R; Juhász P; Nagy K; Várady G; Vörös D; Zámbó B; Sarkadi B; Poór G
    Clin Exp Med; 2023 Aug; 23(4):1277-1284. PubMed ID: 35939175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethnic differences in ATP-binding cassette transporter, sub-family G, member 2 (ABCG2/BCRP): genotype combinations and estimated functions.
    Sakiyama M; Matsuo H; Takada Y; Nakamura T; Nakayama A; Takada T; Kitajiri S; Wakai K; Suzuki H; Shinomiya N
    Drug Metab Pharmacokinet; 2014; 29(6):490-2. PubMed ID: 24869748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABCG2 dysfunction increases serum uric acid by decreased intestinal urate excretion.
    Takada T; Ichida K; Matsuo H; Nakayama A; Murakami K; Yamanashi Y; Kasuga H; Shinomiya N; Suzuki H
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):275-81. PubMed ID: 24940679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of ABCG2-mediated extra-renal urate excretion in hemodialysis patients.
    Ohashi Y; Toyoda M; Saito N; Koizumi M; Kanai G; Komaba H; Kimura M; Wada T; Takahashi H; Takahashi Y; Ishida N; Kakuta T; Fukagawa M; Ichida K
    Sci Rep; 2023 Jan; 13(1):93. PubMed ID: 36639673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients.
    Stiburkova B; Pavelcova K; Pavlikova M; Ješina P; Pavelka K
    Arthritis Res Ther; 2019 Mar; 21(1):77. PubMed ID: 30894219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Characterization of Clinically-Relevant Rare Variants in
    Toyoda Y; Mančíková A; Krylov V; Morimoto K; Pavelcová K; Bohatá J; Pavelka K; Pavlíková M; Suzuki H; Matsuo H; Takada T; Stiburkova B
    Cells; 2019 Apr; 8(4):. PubMed ID: 31003562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABCG2: the molecular mechanisms of urate secretion and gout.
    Woodward OM
    Am J Physiol Renal Physiol; 2015 Sep; 309(6):F485-8. PubMed ID: 26136557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.